Kallistatin reduces viability and increases apoptosis in breast cancer cells.
Kallistatin induces autophagy via suppressing Wnt signaling.
Kallistatin via its active site regulates miR-21, miR-203 and miR-34a synthesis.
Kallistatin inhibits miR-203 and increases SOCS3 levels via PKC-ERK signaling.
Novel mechanisms of kallistatin in cancer cell death and tumor development.